Regier DA, Narrow WE, Rae DS, Manderscheid RW, Locke BZ, Goodwin FK. The de facto US mental and addictive disorders service system: Epidemiologic
Catchment Area prospective 1-year prevalence rates of disorders and services. Arch Gen Psychiatry.1993;50:85-94.
Kessler RC, McGonagle KA, Zhao S.
et al. Lifetime and 12-month prevalence of DSM-III-R
psychiatric disorders in the United States: results from the National Comorbidity
Survey. Arch Gen Psychiatry.1994;51:8-19.
Weissman MM, Bland RC, Canino GJ.
et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA.1996;276:293-299.
Wells KB, Sherbourne CD. Functioning and utility for current health of patients with depression
or chronic medical conditions in managed, primary care practices. Arch Gen Psychiatry.1999;56:897-904.
Hirschfeld RM, Montgomery SA, Keller MB.
et al. Social functioning in depression: a review. J Clin Psychiatry.2000;61:268-275.
Spitzer RL, Kroenke K, Linzer M.
et al. Health-related quality of life in primary care patients with mental
disorders: results from the PRIME-MD 1000 Study. JAMA.1995;274:1511-1517.
Wells KB, Stewart A, Hays RD.
et al. The functioning and well-being of depressed patients: results from
the Medical Outcomes Study. JAMA.1989;262:914-919.
Murray CJ, Lopez AD. Evidence-based health policy-lessons from the Global Burden of Diesease
Nelson JC. A review of the efficacy of serotonergic and noradrenergic reuptake
inhibitors for treatment of major depression. Biol Psychiatry.1999;46:1301-1308.
Schatzberg AF. Noradrenergic versus serotonergic antidepressants: predictors of treatment
response. J Clin Psychiatry.1998;59(suppl 14):15-18.
Markowitz JC. Developments in interpersonal psychotherapy. Can J Psychiatry.1999;44:556-561.
American Psychiatric Association. Practice guideline for the treatment of patients with major depressive
disorder (revision). Am J Psychiatry.2000;157(suppl):1-45.
Depression Guideline Panel. Depression in Primary Care, Volume 2: Treatment of
Major Depression. Rockville, Md: Public Health Service, US Dept of Health and Human
Services; 1993. AHCPR publication 93-0551.
Persons JB, Thase ME, Crits-Christoph P. The role of psychotherapy in the treatment of depression: review of
two practice guidelines. Arch Gen Psychiatry.1996;53:283-290.
Kessler RC, Zhao S, Katz SJ.
et al. Past-year use of outpatient services for psychiatric problems in the
National Comorbidity Survey. Am J Psychiatry.1999;156:115-123.
Narrow WE, Regier DA, Rae DS, Manderscheid RW, Locke BZ. Use of services by persons with mental and addictive disorders: findings
from the National Institute of Mental Health Epidemiologic Catchment Area
program. Arch Gen Psychiatry.1993;50:95-107.
Edwards WS, Berlin M. National Medical Expenditure Survey: Questionnaires
and Data Collection Methods for the Household Survey and Survey of American
Indians and Alaska Natives. Washington, DC: US Dept of Health and Human Services; 1989. Publication
Cohen SB. Sample Design of the 1997 Medical Expenditure Panel
Survey Household Component. Rockville, Md: Agency for Healthcare Research and Quality; 2000.
MEPS Methodology Report 11. AHRQ publication 01-0001.
Cohen S, DiGaetano R, Waksberg J. Sample Design of the 1987 Household Survey, National
Medical Expenditure Survey Methods 3. Rockville, Md: Agency for Healthcare Research and Quality; 1991.
AHCPR publication 91-0037.
International Classification of Diseases, Ninth Revision, Clinical
Modification. Washington, DC: Public Health Service, US Dept of Health and Human
Physicians' Desk Reference . Montvale, NJ: Medical Economics Co Inc; 1997.
Shah BV, Barnwell BG, Dieler GS. SUDAAN User's Manual, Release 7.5. Research Triangle Park, NC: Research Triangle Institute; 1997.
Peretti S, Judge R, Hindmarch I. Safety and tolerability considerations: tricyclic antidepressants vs
selective serotonin reuptake inhibitors. Acta Psychiatr Scand Suppl.2000;403(suppl):17-25.
Trindade E, Menon D, Topfer LA, Coloma C. Adverse effects associated with selective serotonin reuptake inhibitors
and tricyclic antidepressants: a meta-analysis. CMAJ.1998;159:1245-1252.
Olfson M, Marcus SC, Pincus HA, Zito JM, Thompson JW, Zarin DA. Antidepressant prescribing practices of outpatient psychiatrists. Arch Gen Psychiatry.1998;55:310-316.
Nikelly AG. Drug advertisements and the medicalization of unipolar depression in
women. Health Care Women Int.1995;16:229-242.
Goldman R, Montagne M. Marketing "mind mechanics": decoding antidepressant advertisements. Soc Sci Med.1986;22:1047-1058.
Spitzer RL, Williams JB, Kroenke K.
et al. Utility of a new procedure for diagnosing mental disorders in primary
care: the PRIME-MD 1000 study. JAMA.1994;272:1749-1756.
Leon AC, Olfson M, Weissman MM.
et al. Brief screens for mental disorders in primary care. J Gen Intern Med.1996;11:426-430.
Zimmerman M, Lish JD, Farber NJ.
et al. Screening for depression in medical patients. Is the focus too narrow? Gen Hosp Psychiatry.1994;16:388-396.
Regier DA, Hirschfeld RM, Goodwin FK, Burke JF, Lazar JB, Judd LL. The NIMH Depression Awareness, Recognition, and Treatment Program:
structure, aims, and scientific basis. Am J Psychiatry.1988;145:1351-1357.
Greenfield SF, Reizes JM, Muenz LR, Kopans B, Kozloff RC, Jacobs DG. Treatment for depression following the 1996 National Depression Screening
Day. Am J Psychiatry.2000;157:1867-1869.
Roper Reports: To Medicate: What People Do for Minor Health Problems. New York, NY: Roper Organization; October 1986. Roper Reports 86-88.
Langer F. Use of anti-depressants is a long-term practice. April 10, 2000. Available at: http://abcnews.com. Accessed
December 17, 2000.
Kihlstrom LC. Managed care and medication compliance: implications for chronic depression. J Behav Health Serv Res.1998;25:367-376.
Dana RH, Conner MG, Allen J. Quality of care and cost-containment in managed mental health: policy,
education, research, advocacy. Psychol Rep.1996;79:1395-1422.
Frank RG, Huskamp HA, McGuire TG, Newhouse JP. Some economics of mental health "carve-outs." Arch Gen Psychiatry.1996;53:933-937.
Sturm R. Tracking changes in behavioral health services: how have carve-outs
changed care? J Behav Health Serv Res.1999;26:360-371.
Blazer DG, Kessler RC, McGonagle KA, Swartz MS. The prevalence and distribution of major depression in a National Community
Sample: the National Comorbidity Survey. Am J Psychiatry.1994;151:979-986.
Keller MB, McCullough JP, Klein DN.
et al. A comparison of nefazadone, the cognitive-behavioral analysis system
of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med.2000;342:1462-1470.
Thase ME, Greenhouse JB, Frank E.
et al. Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy
combinations. Arch Gen Psychiatry.1997;54:1009-1015.